Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ahmed Mostafa Gad"'
Autor:
Taher Al-Tweigeri, Noura N. AlRaouji, Asma Tulbah, Maria Arafah, Mouad Aboussekhra, Falah Al-Mohanna, Ahmed Mostafa Gad, Abdelmonneim M. Eldali, Tusneem A. Elhassan, Abdelilah Aboussekhra
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-15 (2022)
Abstract Background Locally advanced breast cancer (LABC), the most aggressive form of the disease, is a serious threat for women's health worldwide. The AU-rich RNA-binding factor 1 (AUF1) promotes the formation of chemo-resistant breast cancer stem
Externí odkaz:
https://doaj.org/article/fdfaf012f7d645afbcc26f3df30413d9
Autor:
Shouki Bazarbashi, Ahmed Alzahrani, Ali Aljubran, Mahmoud Elshenawy, Ahmed Mostafa Gad, Fatima Maraiki, Noura Alzannan, Tusneem Elhassan, Ahmed Badran
Publikováno v:
The Oncologist. 28:e254-e262
Background Tyrosine kinase inhibitors remain a cornerstone in managing metastatic clear cell renal cell carcinoma (RCC). The 4 weeks on/2 weeks off intermittent sunitinib schedule could result in rebound angiogenesis and tumor progression in the 2-we
Autor:
Bader Alshamsan, Ahmed Mostafa Gad, Maaz Kamal Alata, Mashari Alzahrani, Tusneem Elhassan, Jean Paul Atallah
Publikováno v:
Journal of Oncology. 2022:1-9
Background. Numerous chemotherapeutic agents have antitumor activity in recurrent/metastatic (R/M) nasopharyngeal cancer (NPC). Evidence of capecitabine’s effectiveness as monotherapy is limited. Capecitabine tolerability in solid malignancies has
Autor:
Shouki Bazarbashi, Ahmed Badran, Ahmed Mostafa Gad, Ali Aljubran, Ahmed Alzahrani, Aisha Alshibani, Reem Alrakaf, Tusneem Elhassan, Abdullah Alsuhaibani, Mahmoud A. Elshenawy
Publikováno v:
Annals of surgical oncology. 30(1)
Autor:
Mohamed Aseafan, Ahmed Mostafa Gad, Bader Alshamsan, Naela Agha, Ali Alhanash, Ali H Aljubran, Ahmed Alzahrani, Shouki Bazarbashi
Publikováno v:
Cureus.
Background Gastric cancer (GC) carries a poor survival outcome despite the availability of many therapeutic agents active in treatment. In this study, we aimed to evaluate the survival outcomes of metastatic GC treatment from a single center in Saudi
Autor:
Shouki Bazarbashi, Ahmed Badran, Ahmed Mostafa Gad, Ali Aljubran, Ahmed Alzahrani, Aisha Alshibani, Reem Alrakaf, Tusneem Elhassan, Abdullah Alsuhaibani, Mahmoud A. Elshenawy
Publikováno v:
Annals of surgical oncology. 30(1)
The peritoneum frequently is the only recurrence site after radical resection of gastric cancer. Data suggest that hyperthermic intraperitoneal chemotherapy (HIPEC) and intraoperative radiotherapy (IORT) reduce peritoneal recurrence and possibly impr
Autor:
Mohammed Alghamdi, Shouki Bazarbashi, Mervat Mahrous, Omar Alshaer, Ahmed Mostafa Gad, Mohamed Aseafan, Mai Abdelgelil, Redhwan Mohammed Alshabi, Hosam Ali Alghanmi, Nasser Ahmed Naser, Husam Al Hariri, Abdulaziz ALHamad, Khalid Al-Saleh, Nashwa Abdel-Aziz, Sherif Elsamany
Publikováno v:
Journal of oncology. 2022
Background. The outcome of patients with refractory metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI) beyond the second-line has not been studied in Saudi Arabia. Therefore, this multicenter retrospective analysis was
Autor:
Ahmed Mostafa Gad, Adhar AlSayed, Aisha AlShibani, Taher Twegieri, Kausar Suleman, Dahish Ajarim
Publikováno v:
Cancer Research. 83:P4-01
Background: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in combination with hormonal treatment is the standard of care in the management of hormone receptor positive, human epidermal growth factor receptor-2 (Her2) negative metastatic breast canc
Autor:
Shouki Bazarbashi, Ahmed M Alzahrani, Ali H Aljubran, Mahmoud Abdelsatar Elshenawy, Ahmed Mostafa Gad, Fatma Maraiki, Noura Alzannan, Tusneem Elhassan, Ahmed Ali Badran
Publikováno v:
Journal of Clinical Oncology. 41:665-665
665 Background: Tyrosine kinase inhibitors remain a corner stone in the management of metastatic clear cell renal cell carcinoma (RCC). The intermittent schedule of sunitinib with 4 weeks on/2 weeks off could result in a rebound angiogenesis and tumo
Autor:
Shouki Bazarbashi, Ahmed Mostafa Gad, Ahmed Ali Badran, Mahmoud Elshenawy, Ali H Aljubran, Ahmad Al Zahrani, Hadeel Al Manae, Abdullah Alsuhaibani, Ahmed Elashwah, Mohammed Neimatallah, Alaa Abdul Jabbar, Luai Ashari, Samar Al Homoud, Hazem Ghebeh, Nasser Alsanea, Mohammed Mohiuddin
Publikováno v:
Journal of Clinical Oncology. 40:94-94
94 Background: The achievement of a pathological complete response with preoperative concurrent chemoradiotherapy in locally advanced rectal cancer has been found to correlate with a reduced incidence of local and distant recurrences. With the radios